Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Nov 18, 2026 |
EVP Commercial
Trans History: 196
|
EVP Commercial | Form 4 | Other acquisition or disposition | -- | -- | 219 |
| Nov 18, 2026 |
Co-Chief Scientific Officer
Trans History: 316
|
Co-Chief Scientific Officer | Form 4 | Other acquisition or disposition | -- | -- | 4,414 |
| Nov 18, 2026 |
Director
Trans History: 372
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 750 |
| Nov 18, 2026 |
Director
Trans History: 372
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 400 |
| Nov 18, 2026 |
Director
Trans History: 372
|
Director | Form 4 | Other acquisition or disposition | -- | -- | 1,000 |
| Nov 17, 2026 |
Co-Chief Scientific Officer
Trans History: 316
|
Co-Chief Scientific Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 93 | $949.69 | 51,697 |
| Nov 17, 2026 |
Co-Chief Scientific Officer
Trans History: 316
|
Co-Chief Scientific Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 74 | $950.61 | 51,623 |
| Nov 17, 2026 |
Co-Chief Scientific Officer
Trans History: 316
|
Co-Chief Scientific Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 298 | $951.75 | 51,325 |
| Nov 17, 2026 |
Co-Chief Scientific Officer
Trans History: 316
|
Co-Chief Scientific Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 220 | $952.75 | 51,105 |
| Nov 17, 2026 |
Co-Chief Scientific Officer
Trans History: 316
|
Co-Chief Scientific Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 671 | $953.69 | 50,434 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.